Polaris Pharmaceuticals 2025 Q4 Financial Report
NQ Score
55/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Polaris Pharmaceuticals, Inc. (stock code: 6550) reported a basic EPS of -5.10 NTD, revenue of 0.41 billion NTD, and a net loss after tax of 3.945 billion NTD for the fourth quarter of 2025.
AI analysis data is not yet available.